Deaconson T F, Wilson S D, Cerletty J M, Komorowski R A
Surgery. 1986 Dec;100(6):1116-20.
Controversy continues regarding the extent of thyroidectomy appropriate for patients with radiation-associated thyroid nodules. The incidence of cancer in this group of patients is more than 50% when near total or total thyroidectomy is done and all thyroid tissue is serially sectioned and examined. Tumor multicentricity is common. Is total or near total thyroidectomy warranted in all of these patients? A prospective study and follow-up program of 2118 patients with prior low-dose head and neck irradiation who entered into a thyroid screening program allowed us to examine how the extent of thyroidectomy influenced the clinical course of these patients. Near total or total thyroidectomy was performed in 59 patients (36 had cancer), and limited thyroid resection, that is, lobectomy or less, was done in 78 patients (four of whom had cancer). During follow-up, only three patients have developed recurrent cancer; two had near total thyroidectomy and one had total thyroidectomy at first operation. Two patients with limited thyroid resection have had reoperation for new thyroid nodules, both of whom had benign nodules. We conclude that although limited thyroid resection may leave occult malignancies in unresected thyroid tissue, there is no significant difference in outcome between patients with limited resection and those with near total or total thyroidectomy after a 12-year follow-up of the program. Significant differences in cancer recurrence rats may occur with longer follow-up.
对于接受过放射性治疗的甲状腺结节患者,合适的甲状腺切除范围仍存在争议。当进行近全甲状腺切除术或全甲状腺切除术,并对所有甲状腺组织进行连续切片检查时,这类患者的癌症发生率超过50%。肿瘤多中心性很常见。所有这些患者都需要进行全甲状腺切除术或近全甲状腺切除术吗?一项针对2118例既往接受过低剂量头颈放疗并参加甲状腺筛查项目患者的前瞻性研究及随访计划,使我们能够研究甲状腺切除范围如何影响这些患者的临床病程。59例患者接受了近全甲状腺切除术或全甲状腺切除术(其中36例患有癌症),78例患者进行了有限的甲状腺切除术,即叶切除术或更小范围的切除(其中4例患有癌症)。在随访期间,只有3例患者出现了复发性癌症;2例首次手术时接受了近全甲状腺切除术,1例接受了全甲状腺切除术。2例接受有限甲状腺切除术的患者因新发甲状腺结节接受了再次手术,二者均为良性结节。我们得出结论,虽然有限的甲状腺切除术可能会在未切除的甲状腺组织中留下隐匿性恶性肿瘤,但在对该项目进行12年随访后,有限切除患者与近全甲状腺切除术或全甲状腺切除术患者的预后没有显著差异。随着随访时间延长,癌症复发率可能会出现显著差异。